About Us
COMPANY PROFILE
IIT
"Vita Research accelerates clinical validation for early-stage biotech and their investors. Unlike traditional CROs, we are engineered for agility. We exist to solve the core challenges of startups and VCs where time and capital are paramount. Backed by an exclusive network of top-tier GMP facilities and animal model partners, we streamline your path from concept to data. From securing seed funding with pilot data to validating mechanisms via IIT studies, we handle the operational complexity. You focus on the vision."
IIT
Early stage research
Accelerate from bench to first-in-human data with Vita Research's early-stage IIT services. We support exploratory study design, feasibility assessment, IRB/EC 路路路
Comprehensive PK/PD support for IIT studies: ADME characterization, bioanalytical method validation, population pharmacokinetic (PopPK) modeling, and exposure-response analysis. Specialized PK evaluation for hepatic/renal impairment, elderly, and pediatric populations. Translating pharmacokinetic da路路路
Optimize dosing strategies through IIT-based dose-determination studies. Vita Research designs dose-escalation trials (3+3, BOIN, mTPI), manages DLT assessment with independent DMC/DSMB oversight, and determines MTD/RP2D. Integrated dose-exposure-response analysis supports informed go/no-go decision路路路